Boundless Bio, Inc.
BOLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782303
In the last 90 days, Boundless Bio, Inc. insiders filed 4 open-market purchases and 2 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $38.3M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Boundless Bio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 55 | 55 | 0 |
| Shares | 13.3M | 13.0M | −313.2K (−2.4%) |
| Value | $46.1M | $37.6M | −$8.48M (−18.4%) |
New holders (9)
Institutions that held Boundless Bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boxer Capital Management, LLC | 250,000 | $725.0K | 0.06% |
| Almitas Capital LLC | 192,007 | $556.8K | 0.12% |
| Acadian Asset Management LLC | 22,087 | $63.0K | 0.00% |
| Nuveen Asset Management, LLC | 21,523 | $62.4K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 12,272 | $35.6K | 0.00% |
| Verition Fund Management LLC | 11,665 | $33.8K | 0.00% |
| SG Americas Securities, LLC | 10,753 | $31.0K | 0.00% |
| Nisa Investment Advisors, LLC | 388 | $1.13K | 0.00% |
| Deutsche Bank AG | 97 | $281 | 0.00% |
Sold out (9)
Institutions that held Boundless Bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Boxer Capital, LLC | 711,329 | $2.47M |
| Norges Bank | 157,211 | $545.5K |
| Logos Global Management LP | 58,903 | $204.4K |
| Renaissance Technologies LLC | 28,700 | $99.6K |
| Point72 (DIFC) Ltd | 28,079 | $97.4K |
| Ovata Capital Management Ltd | 25,000 | $86.8K |
| ExodusPoint Capital Management, LP | 17,328 | $60.0K |
| Point72 Asia (Singapore) Pte. Ltd. | 826 | $2.87K |
| Capital Performance Advisors LLP | 42 | $146 |